Department of Rheumatology of the First Affiliated Hospital, Weifang Medical University, Weifang, China.
Central Laboratory of the First Affiliated Hospital, Weifang Medical University, Weifang, China.
Front Immunol. 2021 Sep 16;12:714832. doi: 10.3389/fimmu.2021.714832. eCollection 2021.
Systemic lupus erythematosus (SLE) is a common autoimmune connective tissue disease with unclear etiology and pathogenesis. Mesenchymal stem cell (MSC) and MSC derived extracellular vesicles (EVs) play important roles in regulating innate and adaptive immunity, which are involved in many physiological and pathological processes and contribute to the immune homeostasis in SLE. The effects of MSCs and EVs on SLE have been drawing more and more attention during the past few years. This article reviews the immunomodulatory effects and underlying mechanisms of MSC/MSC-EVs in SLE, which provides novel insight into understanding SLE pathogenesis and guiding the biological therapy.
系统性红斑狼疮(SLE)是一种常见的自身免疫性结缔组织病,病因和发病机制尚不清楚。间充质干细胞(MSC)和 MSC 衍生的细胞外囊泡(EVs)在调节先天和适应性免疫中发挥重要作用,参与许多生理和病理过程,并有助于 SLE 中的免疫稳态。近年来,MSC 和 EVs 对 SLE 的影响引起了越来越多的关注。本文综述了 MSC/MSC-EVs 在 SLE 中的免疫调节作用及其潜在机制,为理解 SLE 的发病机制和指导生物治疗提供了新的见解。